Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Joint Pain Injections Market Size Changed, over the years?

The market size for injections addressing joint pain has experienced a quick expansion in past years. Expansion is projected from $5.6 billion in 2024 to $6.17 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 10.1%. Factors responsible for the growth during the historic period include a rise in the elderly population, an increase in arthritis cases, global health campaigns, the digitalization of healthcare, and heightened awareness about managing chronic pain.

How Much Will the Joint Pain Injections Market Be Worth in 2029?

Over the forthcoming years, remarkable expansion is anticipated in the joint pain injections market, with a projection to reach $9.81 billion in 2029, reflecting a compound annual growth rate (CAGR) of 12.3%. The growth during the projected period is likely to be driven by factors such as the development of telehealth services, customized pain management strategies, patient enlightenment and empowerment, sustainable health care procedures, and nutritional backing. The forecast period will also see major trends including the rise of regenerative medicine, personalized pain management, the introduction of innovative injection materials, burgeoning rehabilitation technologies, and the advent of artificial intelligence enhanced injections.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6482&type=smp

Which is the Largest Company in the Joint Pain Injections Market?

Major companies operating in the joint pain injections market include Seikagaku Corporation, Flexion Therapeutics Inc., Zimmer Biomet Holdings Inc., Sanofi S.A., Anika Therapeutics Inc., Abbvie Inc., Bioventus Inc., Eli Lilly and Company, Ferring Pharmaceuticals Inc., Pfizer Inc., Teva Pharmaceutical Industries Limited, Johnson & Johnson Services Ltd., Merck & Co. Inc., GlaxoSmithKline plc, Novartis AG, AstraZeneca plc, Roche Holding AG, Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, Takeda Pharmaceutical Company Limited, Bayer AG, Astellas Pharma Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Ipsen SA, Mallinckrodt Pharmaceuticals Ltd., Mylan N.V., Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., Zydus Lifesciences Limited

What Are the Main Market Drivers in the Joint Pain Injections Industry?

The joint pain injections market is projected to grow due to the increasing occurrence of arthritis and musculoskeletal ailments. These are among the leading disabilities around the globe, with low back pain known to be the most frequent impairment in around 160 countries. To relieve the pain and inflammation, patients are resorting to injections. For example, as per the Australian Institute of Health and Welfare, a government agency in Australia, rheumatoid arthritis accounted for 2.0% of the total disease burden and 16% of the total burden related to musculoskeletal conditions in June 2023. In the preceding year, it was accountable for 1,322 fatalities, translating to 5.1 deaths for every 100,000 individuals, making up 0.7% of all deaths. As a result, the escalating rate of arthritis and musculoskeletal disorders is fuelling the growth of the joint pain injections market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=6482&type=smp

How Is the Joint Pain Injections Market Segments Structured?

The joint pain injections market covered in this report is segmented –

1) By Type Of Injection: Steroid Joint Injection, Hyaluronic Acid Injections, Platelet-Rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Other Type Of Injections

2) By Joint Type: Hip Joint, Knee And Ankle, Shoulder And Elbow, Facet Joints Of The Spine, Other Joint Types

3) By Distribution channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Steroid Joint Injection: Corticosteroid Injections, Combination Steroid Injections

2) By Hyaluronic Acid Injections: Single-Dose Hyaluronic Acid Injections, Multi-Dose Hyaluronic Acid Injections

3) By Platelet-Rich Plasma (PRP) Injections: Autologous PRP Injections, Allogeneic PRP Injections

4) By Placental Tissue Matrix (PTM) Injections: Amniotic Fluid Injections, Placental Derived Cell Injections

5) By Other Types of Injections: Bone Marrow Aspirate Concentrate (BMAC) Injections, Stem Cell Injections, Genetically Engineered Cell Injections

What Strategic Trends Are Transforming the Joint Pain Injections Market?

Leading companies in the joint pain injection market are concentrating on bringing forward new innovations such as single-injection formulations that prioritize user convenience. Single-injection formulations, a drug delivery mechanism, are designed to administer a precise dosage of medicine in a singular dose, ensuring lasting therapeutic effects without the need for recurring doses. For instance, LG Chem Ltd., based in South Korea, in July 2024, introduced Synovian, a pioneering treatment for knee osteoarthritis, in China with a singular injection feature, establishing it as the first product of its kind in the nation. Aimed at tapping into a substantial market, estimated at about KRW 200 billion (approximately USD 150 million), it employs unique technology to champion innovation in meeting patient requirements, emphasizing delivering effective relief with minimal administration complexities.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/joint-pain-injections-global-market-report

Which Global Regions Offer the Highest Growth in the Joint Pain Injections Market?

North America was the largest region in the joint pain injections market in 2024. The regions covered in the joint pain injections market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6482

This Report Delivers Insight On:

1. How big is the joint pain injections market, and how is it changing globally?

2. Who are the major companies in the joint pain injections market, and how are they performing?

3. What are the key opportunities and risks in the joint pain injections market right now?

4. Which products or customer segments are growing the most in the joint pain injections market?

5. What factors are helping or slowing down the growth of the joint pain injections market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model